← All trials
NCT03766321
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 28, 2019
- Primary completion
- Feb 28, 2022
- Completion date
- Feb 28, 2022
- First posted
- —
- Last posted
- —
- Enrollment
- 42
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of Modena and Reggio EmiliaLead sponsor
- Catholic University of Sacred Heart, RomeCollaborator
- University of FlorenceCollaborator
- University of PerugiaCollaborator
- University of Modena and Reggio EmiliaCollaborator
- Campus Bio-Medico UniversityCollaborator
- University of Modena and Reggio EmiliaReponsible party - principal investigator
- D'Annunzio University of Chieti–PescaraCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.